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The mitochondrial lifecycle (mitochondrial biogenesis, dynamics, and removal by
mitophagy) is carefully orchestrated to ensure the efficient generation of cellular energy
and to maintain reactive oxygen species (ROS) production within an optimal range for
cellular health. Based on latest research, these processes largely depend on mitochondrial
interactions with other cell organelles, so that the ER- and peroxisome-mitochondrial
connections might intervene in the control of cellular energy flow. Damaged organelles
are cleared by autophagic mechanisms to assure the quality and proper function of the
intracellular organelle pool. Nitric oxide (NO) generated through the endothelial nitric
oxide synthase (eNOS) acts a gas signaling mediator to promote mitochondrial biogenesis
and bioenergetics, with a favorable impact in diverse chronic diseases of the elderly.
Obesity, diabetes and aging share common pathophysiological mechanisms, including
mitochondrial impairment and dysfunctional eNOS. Here we review the evidences that
eNOS-dependent mitochondrial biogenesis and quality control, and possibly the complex
interplay among cellular organelles, may be affected by metabolic diseases and the
aging processes, contributing to reduce healthspan and lifespan. Drugs or nutrients
able to sustain the eNOS-NO generating system might contribute to maintain organelle
homeostasis and represent novel preventive and/or therapeutic approaches to chronic
age-related diseases.
Keywords: mitochondrial biogenesis, peroxisomes, endoplasmic reticulum, aging, nitric oxide, endothelial NO
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INTRODUCTION
Nutrition and medical advancements leading to increased lifes-
pan are not adequately translating into improved healthspan—
i.e., into increased number of healthy, fully functional years—
in modern societies (Valerio et al., 2011). Particularly, the
high prevalence of non-communicable diseases and frailty are
major concerns in elderly people (Hunter and Reddy, 2013).
Globally, the problems are expected to worsen: the World Health
Organization estimates that nearly one in four people will be
older than 60 by 2050. It is also estimated that approximately one
in three adults is obese in Western countries (Ogden et al., 2014).
Both aging and obesity are major risk factors for several diseases
such as diabetes, heart disease, stroke and certain types of cancers.
Gaining wellbeing at all stages of life and maximizing healthy life
expectancy are major goals of the post-2015 sustainable agenda
(Hunter and Reddy, 2013).
Present-day gerontology research suggests that, unlike tradi-
tional approaches that focus on specific diseases, deciphering,
and targeting the aging process itself could be the most clever
approach toward increased healthspan. Nonetheless, the emerg-
ing epidemics of obesity and diabetes (whose prevalence at all ages
is growing due to unhealthy habits and economic crisis) can coun-
teract the benefits of reducing chronic disorders throughout the
world. Preventing the metabolic consequences of inadequate diet
through groundbreaking transdisciplinary investigation should
be a primary research focus (Nisoli and Valerio, 2014).
Multiple cell effectors work together to cause the senescent
cell phenotype. Particularly, two cellular organelles—nucleus and
mitochondrion—have been implicated in the “wear and tear”
aspects of aging (Nisoli and Valerio, 2014). Other organelles,
including the endoplasmic reticulum (ER), peroxisomes and lyso-
somes, have been studied in relation to aging mechanisms. Since
cellular organelles act in a coordinated manner, we have recently
proposed an aging organelle network theory, exploring the possi-
bility that the complex interplay among mitochondria and other
cellular organelles may be affected by the aging process (Nisoli
and Valerio, 2014). An urgent challenge is to uncover the molec-
ular mechanism(s) regulating the endomembrane systems in
cellular aging. Here we review the recent evidence indicating the
relevant role played by the nitric oxide (NO) signaling system in
the improvement of the age-related metabolic disorders and in
healthspan extension. Moreover, we will summarize the current
knowledge regarding the role of NO in organelle crosstalk and
quality control.
HEALTHY EFFECTS OF CALORIE RESTRICTION AND
EXERCISE: THE ROLE OF eNOS AND MITOCHONDRIAL
BIOGENESIS
NITRIC OXIDE, REACTIVE NITROGEN SPECIES AND THE HORMETIC
EFFECT
NO is highly lipophilic, hyperreactive, diffusible free radical
gas (Dudzinski et al., 2006) endowed with a short half-life
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in biological fluids and acting as a fundamental cell signaling
molecule in critical physiological processes (Moncada et al., 1991;
Pacher et al., 2007). When reacting with superoxide (O•−2 ), NO
can give rise to reactive nitrogen species (RNS) which, similarly
to reactive oxygen species (ROS) can mediate cellular damage
in a wide range of conditions (Pacher et al., 2007) (Figure 1).
Traditionally, ROS are represented as unwanted by-products of
mitochondrial oxidative phosphorylation and major players in
decreased lifespan, based on the Harman’s free radical theory
of aging (Harman, 2009). With the aim to postpone the aging
decay, great efforts have been made to prevent ROS formation
by administering high doses of natural or synthetic antioxidant
compounds (Ristow and Zarse, 2010). However, several prospec-
tive clinical trials designed to demonstrate the health-promoting
effects of diverse antioxidants failed, at best showing no benefits
(vitamin C and selenium) or even promoting diseases or increas-
ing mortality in humans (beta carotene, vitamin A, and vitamin
E) introducing the so-called “antioxidant paradox” (Ristow and
Zarse, 2010; Li et al., 2014; Nisoli and Valerio, 2014). Present
evidence does not support antioxidant supplements for primary
or secondary disease prevention (Bjelakovic et al., 2012). Indeed,
the latest findings (in contrast to Harman’s original hypothesis)
suggest that—within specific concentrations and exposure-time
intervals—ROS behave as key signaling molecules potentially
involved in lifespan (Kaelin, 2005; Loh et al., 2009; Ristow et al.,
2009; Ristow and Zarse, 2010; Ristow and Schmeisser, 2014),
possibly by upregulating endogenous antioxidant levels in the
human body. The “mitochondrial hormesis” or “mitohorme-
sis” hypothesis suggest that strategies activating low-level stress
may indeed favor longevity (Tapia, 2006; Ristow and Schmeisser,
2014) (Figure 1). Lately, supplying weak pro-oxidants, with the
aim to promote the composite endogenous antioxidant response,
has been suggested as a more useful approach to the treatment
and prevention of diseases (Halliwell, 2013).
PROLONGEVITY MECHANISMS ACTIVATED BY CALORIE RESTRICTION
In 2003, endogenous NO produced at low doses by endothe-
lial NO synthase (eNOS) was firstly demonstrated to promote
mitochondrial biogenesis in several cells and tissues (Nisoli et al.,
2003, 2004). Since then, eNOS and downstream NO signaling
are appreciated as major metabolic determinants for the regu-
lation of mitochondrial biogenesis (Scarpulla, 2008). The down-
stream induction of the expression of peroxisome proliferator–
activated receptor γ coactivator 1α (PGC-1α) is essential for
this effect (Nisoli et al., 2003). It has been established that
NO-induced mitochondrial biogenesis requires cyclic guanosine
mono-phosphate (cGMP) (Nisoli et al., 2003; Kalogeris et al.,
2014). As a consequence of NO-cGMP production, key nuclear-
encoded mitochondrial biogenesis transcription factors (includ-
ing nuclear respiratory factor-1 and mitochondrial transcription
factor A) are induced, mitochondrial DNA (mtDNA) levels are
increased and mitochondrial function is activated (Nisoli et al.,
2003, 2004). Besides this, NO is able to activate PGC-1α via
AMPK or in a p53-dependent manner, with a possibility of multi-
ple overlapping pathways (Komen and Thorburn, 2014). Further,
NO acting via cGMP induces the expression of the SIRT1 deacety-
lase (Nisoli et al., 2005) a well-known PGC-1α activity inducer, as
discussed below. Clear establishment of the full NO-dependent
FIGURE 1 | eNOS activation promotes mithormesis and healthspan
extension. Calorie restriction (CR) and exercise act as slight stressors
favoring low-level ROS production. Further, CR, exercise and dietary
supplementation with a balanced BCAA-EAA formula enhance eNOS
expression and NO production. The eNOS-NO-PGC1α pathway boosts
mitochondrial renewal, with efficient energy production, and activates the
endogenous antioxidant response. Thus, within a finely tuned cellular range,
NO and ROS activate mithormesis, an adaptive stress resistance program
promoting cell survival and prolonging healthspan. Conversely, cardiovascular
risk factors uncouple eNOS and lead to superoxide (O•−2 ) and peroxynitrite
(ONOO−), a powerful oxidant that initiates a vitious cell-damaging cycle that
favors chronic age-related diseases.
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pathway involved in these phenomena is an interesting point
awaiting further research.
Subsequently it has been reported that eNOS expression is
induced, and NO-dependent mitochondrial biogenesis is aug-
mented, in the every-other-day feeding model of calorie restric-
tion (CR) in mice (Nisoli et al., 2005). Chronic CR without
malnutrition, acting as a low-energy stress condition, is consid-
ered the gold standard intervention to extend lifespan in most
species. Although the possibility that CR could promote lifes-
pan extension in humans is currently debated, the impact of
CR in promoting healthspan by attenuating age-related disease
is a consistent finding (Fontana et al., 2010). Calorie-restricted
mice had upregulated PGC-1α and sirtuin 1 (SIRT1, the mam-
malian deacetylase ortholog of the life-extending yeast gene Sir2)
and induced endogenous antioxidant response (see also details
below) (Nisoli et al., 2005). It should also be mentioned that,
although preliminary evidence suggests that high SIRT1 expres-
sion is not required for CR-induced lifespan extension (Mercken
et al., 2014), its activation extends survival of male mice on a stan-
dard diet (Mercken et al., 2013). Interestingly, both SIRT1 and the
mitochondrial homologous protein SIRT3, which is also induced
by CR, increase eNOS and PGC-1α biological activity through
protein deacetylation (Mattagajasingh et al., 2007; Gouspillou
and Hepple, 2013; Guarente, 2013). Additionally, CR induces
nuclear localization of SIRT1 in a mechanism requiring eNOS,
so that SIRT1 and eNOS may comprise a mutually reinforcing
activity loop (Guarente, 2013).
Notably, the CR effects were blunted in eNOS-null (eNOS−/−)
mice (Nisoli et al., 2005), a strain exhibiting metabolic dysfunc-
tions, age-related diseases and shortened lifespan (Valerio et al.,
2011). The mitochondrial biogenic effect of CR has been recently
challenged in different rodent models (Hancock et al., 2011;
Lanza et al., 2012) particularly due to the lack of demonstration
of increased mitochondrial protein synthesis rate in vivo (Miller
et al., 2012). However, evidence from diverse groups support the
initial findings, demonstrating that CR increases PGC-1α and the
entire paradigmatic transcriptional activation involved in mito-
chondrial biogenesis, as well as key proteins and/or other relevant
markers [including mtDNA abundance and mitochondrial num-
ber] in flyes (Zid et al., 2009), rodents (Sreekumar et al., 2002;
López-Lluch et al., 2006; Civitarese et al., 2007; Cerqueira et al.,
2011) and humans (Civitarese et al., 2007; Mercken et al., 2013).
The above reported controversy is likely amplified by virtue of
the different CR protocols (percent decrease of ad libitum feeding
vs. alternate-day-fasting and/or animal species or strain differ-
ence), an issue to be further elucidated to fully understand the
complexities herein (Gouspillou and Hepple, 2013).
That NO may extend lifespan has been supported by the rel-
evant observations by Li and colleagues (Li et al., 2011). By
screening several high-NO yeast mutant strains and selecting
the top NO producers, the authors showed a positive correla-
tion between increased NO production, mitochondrial respira-
tion, and longevity. Moreover, treatment with the NO donor
S-nitrosoglutathione extended yeast lifespan, in part by increas-
ing stress responses, possibly via inducing a hormetic effect.While
CR significantly increases NO production in yeast, some high-
NO yeast mutants only partially mimicked CR, suggesting that
activation of different subsets of stress response pathway or addi-
tional mechanisms contribute to CR-mediated life extension in
these mutants. Noteworthy in this respect are the recent observa-
tions inC. elegans, a roundworm that lacks NOS and compensates
for its own deficit of NO production by eating its natural food
(bacteria). A recent finding showed that bacterial NO produced
inside the worm acts to promote longevity and stress resistance
via a defined group of genes that function under the dual control
of HSF-1 and DAF-16 transcription factors (Gusarov et al., 2013).
HEALTHSPAN-EXTENDING MECHANISMS OF EXERCISE
Regular exercise has a beneficial impact against various disor-
ders typically accompany aging, including diabetes, sarcopenia,
and osteoporosis, and fosters cardiovascular health (Fontana
et al., 2010). Notwithstanding, exercise intensity, duration, and
frequency needs to be controlled in the elderly since excessive
exercise increases mortality at older ages (de Cabo et al., 2014).
Contrary to CR, which is able to delay aging processes result-
ing in increased mean and maximum lifespan, exercise fails
to extend maximum lifespan (Holloszy, 1998; Mercken et al.,
2012). However, exercise and CR are mechanistically related to
some extent, since both induce mitochondrial biogenesis and
autophagy (He et al., 2012), two strictly interconnected cellu-
lar processes which are coregulated to replace old inefficient
mitochondria with new, fuel-efficient ones (Michel et al., 2012).
Because these two health-promoting interventions also display
distinct molecular signatures (Mercken et al., 2013), the inte-
gration of CR regimens with regular exercise might result in
synergistic healthy effects, as reported measuring insulin sensi-
tivity and circulating C-reactive protein in nonobese subjects (de
Cabo et al., 2014).
Among the physiological adaptations induced by regular exer-
cise, a major event is the upregulation of eNOS expression and
the consequent increase of tissue NO production, an event also
measured in real-time through skeletal muscle microdialysis in
exercising human subjects (Hellsten et al., 2007). This in turn
induces cell glucose uptake in skeletal and cardiac muscle to meet
increased metabolic requirement (Zhang et al., 2007; Lee-Young
et al., 2010; Vettor et al., 2013). Two recent studies provides strong
evidence that the eNOS-NO-PGC-1α-dependent mitochondrial
biogenesis plays a crucial role in the metabolic activation taking
place in heart and white adipose tissue in response to physical
activity (Vettor et al., 2013; Trevellin et al., 2014). At this point, it
is of interest to describe the NO biochemistry and eNOS biology
and to review their relevance in health preservation.
THE DISCOVERY OF NO AS A GASEOUS MESSENGER
As early as 1787, Antoine Lavoisier discovered nitrogen and
named it azote (N), meaning without life, due to its lack of chem-
ical reactivity and inability to support life when provided as the
atmosphere. However, nitrogen is presents in amino acids and
in the bases that form DNA and RNA, and the metabolism of
nitrogenous compounds is central to the metabolic processes of
all living organisms. Unable to utilize inorganic nitrogen, ani-
mals rely on plant foods to acquire nitrogen, and arginine from
seed proteins is their major nitrogen source. Free arginine within
the body also derives from endogenous synthesis and turnover
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of body proteins. Arginine is a so-called conditionally essential
amino acid for humans, since its synthesis cannot fully meet
the needs under certain pathophysiological conditions, includ-
ing hypercatabolic responses to stress or injury. Apart from its
involvement in protein structure and function, arginine has a role
as the precursor for the synthesis of NO (Morris, 2006).
Breakthrough studies conducted around the ‘80s led to the dis-
covery of NO biological actions. Ferid Murad in 1977 discovered
the release of NO from nitroglycerine and its action on vascu-
lar smooth muscle (Katsuki and Murad, 1977). In 1987, Salvador
Moncada and Louis Ignarro independently demonstrated that
the endothelium-derived relaxing factor (discovered by Furchgott
and Zawadzki, 1980) is NO (Ignarro et al., 1987; Palmer et al.,
1987). NO is produced in vary degrees in the cardiovascular, ner-
vous, digestive and immune systems where it modulates a variety
of pathophysiological conditions. NO consists of a single oxygen
atom bonded to a nitrogen atom through a chemical bond that
exhibits partial double bond and partial triple bond character as
a result of an unpaired electron (Dudzinski et al., 2006). As a free
radical, the NO molecule has unique reactivity that is responsible
for its interaction with numerous targets. As a lipophilic gas, NO
acts as an unorthodox messenger molecule, which readily diffuses
and traverses multiple cell membranes to signal at some distance
from its source (Dudzinski et al., 2006).
The effects of NO are mediated by activation of the heme-
containing soluble guanylyl cyclase (sGC), with formation of
cGMP (Katsuki and Murad, 1977). Studies involving bacterial
proteins from the heme-nitric oxide/oxygen (H-NOX) binding
family of gas receptors (sharing high sequence homology and
conserved residues with the sGC heme pocket) help understand-
ing the mechanism of sGC activation. Crucial to NO-dependent
activation of H-NOX proteins is the formation of a five-
coordinate NO complex (Herzik et al., 2014). High-resolution
crystal structures of a bacterial H-NOX protein in the unligated
and NO-bound state show that NO binding leads to a pro-
nounced conformational change in the protein as a result of struc-
tural rearrangements in the heme pocket (Herzik et al., 2014).
NO can also signal independent of cGMP, by (i) competitively
inhibiting cytochrome c oxidase, the terminal heme-containing
enzyme in the mitochondrial electron transport chain; (ii) inter-
acting with critical thiols in proteins leading to S-nitrosation,
which regulates the function of many proteins; (iii) reacting with
superoxide, thus forming RNS and promoting tyrosine nitration
of amino acids, which can also affect protein function (Larsen
et al., 2012).
ADVANCES TOWARD A BETTER UNDERSTANDING OF eNOS
NO is produced by three NOS isoforms: the neuronal (nNOS,
alternatively designated NOS1 as it was the first NOS isoform
to be discovered), inducible (iNOS or NOS2), and endothelial
(eNOS or NOS3) ones. Names of nNOS and eNOS derived from
the tissues in which they were first identified. NOS isoforms differ
in their expression, subcellular localizations and mechanistic fea-
tures, which are responsible for their unique pathophysiological
roles. eNOS is classified as a L-arginine, NADPH: oxygen oxidore-
ductase, utilizing flavins, and tetrahydrobiopterin (BH4) as cofac-
tors and forming homodimers during activation (Förstermann
and Sessa, 2012). The enzymatic reaction generating NO involves
the transfer of electrons from NADPH, via the flavins in the C-
terminal reductase domain, to the heme in theN-terminal oxidase
domain, where the substrate L-arginine is oxidized to L-citrulline
and NO (Qian and Fulton, 2013). To efficiently produce NO,
eNOS must effectively coordinate the binding of multiple sub-
strates and cofactors. Disruption of this highly coordinated catal-
ysis can result in the production of superoxide and peroxynitrite
(Dudzinski et al., 2006).
Constitutively expressed in the endothelium, eNOS is respon-
sible for the formation of vascular NO under physiological con-
dition, and is induced by shear stress or chemical stimuli. The
enzyme is activated by increased intracellular Ca2+, and by a com-
plex integration of transcriptional/post-transcriptional mecha-
nisms and post-translational modifications (serine and tyrosine
phosphorylation; S-nitrosylation, acetylation) as well as by sub-
strate and cofactor availability and protein-protein interaction.
eNOS is enriched in caveolae (the small invaginations of the
plasma membrane, especially abundant in endothelial cells and
adipocytes) whichmay serve as microdomains for optimized NO-
sGC-cGMP signaling (Tsai et al., 2012). Further, native eNOS
can shuttle between distinct subcellular domains, having been
detected in the cytosol, Golgi apparatus, mitochondria, and even
in the nucleus of endothelial cells (Feng et al., 1999), brown
adipocytes (Giordano et al., 2002) and other cells, paralleling sGC
localization (Gobeil et al., 2006). Comprehensive reviews have
been published on eNOS and its regulation and we refer readers
to those articles for complete information (Dudzinski et al., 2006;
Qian and Fulton, 2013).
Well-characterized actions of NO include the stimulation of
vasodilation, vessel formation (Ziche et al., 1994), and mito-
chondrial biogenesis (Nisoli et al., 2003) as well as inhibition
of smooth muscle cell proliferation, leukocyte adhesion, platelet
aggregation, and mitochondrial respiration (Qian and Fulton,
2013). Thus, thanks to its antihypertensive, antithrombotic and
anti-atherosclerotic properties, eNOS-derived NO represents a
key molecule in vasoprotection (Förstermann and Li, 2011).
Following the original study demonstrating that eNOS-derived
NO promotes mitochondrial biogenesis (Nisoli et al., 2003), the
eNOS-NO-PGC-1α pathway has been shown to be involved in
several health-promoting actions. It has been found to be down-
regulated in adipose tissue of obese mice and rats (Valerio et al.,
2006). Consistently, eNOS overexpression exerts anti-obesogenic
effects in high fat-fed mice through improved mitochondrial bio-
genesis and activity in adipose tissue (Sansbury et al., 2012).
The eNOS-NO-PGC-1α pathway is also implicated in anti-aging
effects. Besides its activation in calorie-restricted mice (Nisoli
et al., 2005) it has an essential role in healthspan extension
observed when mice diet is supplemented with a balanced for-
mula of branched-chain amino acids (BCAAs) and other essential
amino acids (EAAs) (D’Antona et al., 2010).
Under high oxidative stress in pathological conditions, eNOS
may become dysfunctional and contribute to cell damage. In
fact, persisting oxidative stress renders eNOS uncoupled (i.e.,
O2 reduction is uncoupled from NO synthesis), such that the
enzyme no longer produces the vasoprotective NO, but superox-
ide (Li et al., 2014). Among the possible mechanisms involved
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in eNOS uncoupling, depletion of the eNOS cofactor BH4
(due ROS-dependent oxidation) is likely to play the major role.
Another cause of eNOS uncoupling is L-arginine deficiency due
to increased arginase activity (Li et al., 2014). Uncoupling of
eNOS further creates a vicious cycle (Figure 1), since super-
oxide and subsequent peroxynitrite overproduction enhances
BH4 oxidation and upregulates arginase expression/activity. Pre-
existing oxidative stress is thus potentiated to the point that it
acts as a crucial determinant in cardiovascular disease (Li et al.,
2014). This particular issue is becoming an urgent research topic,
aimed at identifying therapeutic intervention that optimize eNOS
function.
RELEVANCE OF eNOS IN HUMAN DISEASE AND LONGEVITY
eNOS DYSFUNCTION AND METABOLIC DISEASES
Depletion of the eNOS gene induces hyperinsulinemia and
insulin resistance (Duplain et al., 2001). A body of evidence
also demonstrates that reduced NO bioavailability (as a con-
sequence to multiple-level eNOS dysfunctional regulation) is a
key mechanism of endothelial dysfunction. The complex rela-
tionship between endothelial dysfunction and insulin resistance
in diabetes, obesity and metabolic syndrome has recently been
reviewed (Huang, 2009). Mice lacking eNOS fail to respond
to cold exposure by thermogenesis, and their brown adipose
tissue development and function are defective (Nisoli et al.,
2003; Huang, 2009). Abnormalities in energy homeostasis due to
reduced eNOS-derived NO increase the risk for cardiometabolic
diseases. In fact, eNOS−/− mice are considered a model for the
metabolic syndrome (Nisoli et al., 2007) because they combine its
main defining features, including hypertension, endothelial dys-
function, insulin resistance and obesity. This phenotype is reca-
pitulated in mice bearing unphosphorylatable eNOS mutations
at S1176 (Kashiwagi et al., 2013). Conversely, mice bearing phos-
phomimetic eNOS mutations at S1176, resulting in increased
enzyme activity and NO production, show improved insulin sen-
sitivity and resistance to high fat-induced weight gain (Kashiwagi
et al., 2013). Not only eNOS−/− mice have defective mitochon-
drial biogenesis and function (Nisoli et al., 2003), but also they
fail to activate mitochondrial biogenesis in response to cold, CR,
exercise or dietary interventions (Nisoli et al., 2005; D’Antona
et al., 2010; Vettor et al., 2013; Trevellin et al., 2014). The con-
sequences of reduced NO bioavailability have been explored also
in humans. Downregulation of multiple cell signals converg-
ing in the eNOS-NO system occurs in type 2 diabetes mellitus
(T2DM), and contributes to increase the vulnerability of dia-
betic patients to atherosclerosis, hypertension, and coronary heart
diseases (Sharma and Khanna, 2013).
eNOS DYSFUNCTION IN HEART FAILURE
A deficiency of mitochondrial energetics has been documented
both in cardiac aging and in heart failure. Changes in eNOS
have been described in experimental and human cardiac failure
with somewhat mixed results (Carnicer et al., 2013). Chronic
eNOS deletion has been found to induce age-related con-
centric hypertrophy (Barouch et al., 2002) and to worsen
pathological left ventricular remodeling after myocardial infarc-
tion in mice (Scherrer-Crosbie et al., 2001). Consistently,
cardiomyocyte-restricted eNOS restoration attenuated compen-
satory hypertrophy and improved left ventricular performance
after myocardial infarction (Janssens et al., 2004) and protected
against chronic pressure overload (Buys et al., 2007). However,
eNOS−/− mice displayed modest hypertrophy and preserved
function compared to wild-type mice after chronic transverse
aortic constriction (TAC), a severe condition inducing eNOS
uncoupling and increased ROS production (Takimoto et al.,
2005). Thus, while eNOS is usually protective against maladap-
tive stress, it can paradoxically contribute to cardiac pathology
in uncoupled conditions (Carnicer et al., 2013). Recent evidence
also supports a role for the scaffolding protein Cav-3 in regulating
heart NO-sGC-cGMP signaling. A severe depression of NO-
dependent activation of sGC has been reported in the TACmouse
model, partly due to sGC oxidation owing to its altered inter-
actions with Cav-3 and modified subcellular compartmentation
(Tsai et al., 2012). Interestingly, eNOS-NO signaling contributes
to the beneficial effects of statins, angiotensin converting enzyme
inhibitors and AT1 receptor blockers in experimental heart failure
(Shimokawa and Tsutsui, 2010).
eNOS ALLELIC VARIANTS IN HUMAN DISEASES
Among the several eNOS variants so far described, the eNOS
D298 and IVS18+ 27C alleles have been found to be signifi-
cantly associated to T2DM andmetabolic syndrome (Monti et al.,
2003). In addition, endothelial dysfunction and an atherogenic
profile favoring coronary artery disease (CAD) and resteno-
sis after coronary stent implantation were associated with the
same eNOS variant (Galluccio et al., 2008). A recent investi-
gation further demonstrates the significant association between
eNOS −786C > T polymorphism and CAD (Liu et al., 2014).
Interestingly, the −665C > T polymorphism in the eNOS gene
predicts increased cardiovascular morbidity and mortality inde-
pendently of blood pressure and other risk factors in a general
population of white Europeans (Olivi et al., 2014). Although to
be interpreted with caution, these findings suggest that deficient
NO generation as a consequence of eNOS gene variation possi-
bly contributes to the pathogenesis of complex diseases. Further
research will be necessary to elucidate the role of these variants in
the increased cardiometabolic risk.
eNOS GENE VARIANTS IN LONG-LIVING HUMANS
Exceptional longevity in humans is a complex trait. A number
of genetic variants are associated in centenarians and long-living
individuals. A recent genome-wide association study on 410 long-
livings and 553 young controls has identified the rs10491334
gene variant of the Ca2+/calmodulin-dependent protein kinase
(CAMKIV) (Malovini et al., 2011). Homozygous carriers of
rs10491334 have a significant reduction in CAMKIV expression.
In vitro analysis established that CAMKIV activates the survival
proteins AKT, SIRT1, and FOXO3A (Malovini et al., 2011). The
authors found a reduced frequency of carriers of the minor allele
among centenarians (Malovini et al., 2011). Thus, the results
point to a detrimental role for the rs10491334 allele in aging pro-
cess due to reduced survival genes. Interestingly, the prolongevity
genes activated by CAMKIV (that is AKT, SIRT1, and FOXO3A)
all can promote eNOS activity (Puca et al., 2012; Xia et al., 2013),
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thus suggesting that long-living individuals and centenarians are
selected among those with high NO production.
METABOLIC DISEASES AND SENESCENCE SHARE
MITOCHONDRIAL IMPAIRMENTS
A few years ago, we described a marked reduction in eNOS
expression, mitochondrial biogenesis and ATP production,
together with changes in mitochondrial morphology reminis-
cent of increased fission dynamics, in fat and skeletal muscles
of rodents with genetically- or high fat diet-induced obesity
(Valerio et al., 2006). Obesity is increasingly being interpreted
as a state of premature aging (Tzanetakou et al., 2012; Nisoli
and Valerio, 2014). Notably, NO availability as well as the
mitochondrial biogenic capacity are reduced in aged tissues
(Nisoli and Valerio, 2014). Application of a novel biomarker
of aging has recently revealed a strong correlation between
high body mass index and the epigenetic age of liver tissue,
with reduced expression of nuclear mitochondrial genes that
play a role in oxidative phosphorylation and electron trans-
port (Horvath et al., 2014). Proteomic work lately confirms
that obesity parallels key metabolic perturbations observed in
the aging process (Tzanetakou et al., 2012; de Castro et al.,
2013).
Mitochondrial biology has been extensively investigated in
elderly subjects. Aged human skeletal muscles display increased
mtDNA mutations. Important evidence that hindering mito-
chondrial pathology restores health and longevity has been pre-
sented by Safdar and colleagues, who studied the progeroid mice
which express a mtDNA polymerase-γ variant, and exhibit ele-
vated mtDNA point mutations, systemic mitochondrial dysfunc-
tion, multisystem pathology, and reduced lifespan (Safdar et al.,
2011). Interestingly, endurance exercise training rejuvenated mice
mitochondrial turnover and respiratory capacity, and abolished
symptoms of accelerated aging and premature mortality (Safdar
et al., 2011).
Recent studies revealed a novel molecular circuit linking
nuclear DNA damage to mitochondrial dysfunction in advanced
age, and resulting in organ decline and disease development.
Genetically-induced progressive telomere shortening in mice
induced p53 activation, which directly repressed PGC-1α and
PGC-1β. The deficitary mitochondrial biogenesis and function
resulted in a premature aging phenotype, with heart failure and
liver dysfunction (Sahin et al., 2011). Interestingly, subsequent
work demonstrated that deletion of the telomere binding protein
RAP1 suppresses PGC-1α leading to obesity and insulin resistance
(Duong and Sahin, 2013).
The processes of mitochondrial biogenesis, dynamics, and
mitophagy—the so-called mitochondrial lifecycle—represent
efficient mechanisms ensuring the health of the cellular pool of
mitochondria (see below). Changes in mitochondrial dynam-
ics (increased fission/fragmentation vs. fusion/elongation) pro-
gressively reducing bioenergetic efficiency have recently been
observed in conditions of excess nutrient intake (Liesa and
Shirihai, 2013). Therefore, identification of multiple changes
in the mitochondrial lifecycle provide further evidence linking
hypernutrition/obesity and senescence through shared organelle
dysfunctions, and could explain some of the beneficial effects
associated with CR (Liesa and Shirihai, 2013; Nisoli and Valerio,
2014).
Noteworthy, cell-based studies showed that eNOS-derived
NO delays age-dependent inhibition of telomerase activity, pre-
venting telomere shortening and counteracting the senescence
of endothelial cells (Vasa et al., 2000). Further findings con-
firmed a hierarchical relationship between eNOS activation and
the expression and activity of the catalytic subunit of human
telomerase (hTERT) (Vasa et al., 2000; Farsetti et al., 2009).
Finally, increased NO bioavailability prevents high glucose-
induced endothelial cell senescence (Hayashi et al., 2006), so that
eNOS has recently been proposed as an anti-senescence drug
target (Hayashi et al., 2014).
eNOS-DERIVED NO AND MITOCHONDRIA-ENDOPLASMIC
RETICULUM CONNECTIONS
The endoplasmic reticulum (ER) is a highly dynamic organelle
governing protein post-translational modification, folding, and
oligomerization. Disruption of ER homeostasis lead to accumu-
lation of unfolded/misfolded proteins, a condition commonly
referred to as “ER stress.” To combat ER stress, cells have evolved
a highly conserved adaptive stress response referred to as the
unfolded protein response (UPR). Numerous findings have con-
vinced researchers that the ER can undergo ultrastructural and
functional changes in aged tissues. ER stress is implicated in
age-related disorders, due to the progressive impairment of the
UPR and to the deterioration of diverse ER chaperoning sys-
tems (Brown and Naidoo, 2012). Molecules able to reduce ER
stress, by promoting normal protein folding and/or increasing
the unveiling of misfolded proteins, have been proposed to pre-
vent chronic age-related diseases including neurodegenerative
diseases, diabetes and atherosclerosis (Brown and Naidoo, 2012).
High-resolution microscopy served to demonstrate that func-
tionally and structurally distinct domains in the ER are sites of
membrane contacts with other organelles, where the two mem-
branes are closely apposed without fusing, so that the organelles
maintain their distinct identities. Peculiar contacts have been
described between the ER and the plasma membrane, mitochon-
dria, Golgi, endosomes and peroxisomes, where a variety of cel-
lular events take place. The functional roles of the stable contact
sites between the ER and mitochondria (referred to as mitochon-
dria associated membranes, MAMs) have been reviewed in detail
(Rowland and Voeltz, 2012). Among these, Ca2+ released by the
inositol 1,4,5-triphosphate receptor in the ER is taken up bymito-
chondria where it is required for efficient bioenergetic functions
(Cárdenas et al., 2010). When this Ca2+ transfer is deficitary,
macroautophagy is activated to sustain cell survival (Cárdenas
et al., 2010). Interorganelle contacts also control mitochondrial
biogenesis and dynamics. Mitochondrial fission is driven by
DRP1, a cytoplasmic protein recruited to the ER-mitochondria
contact sites. Mitofusin 2, promoting mitochondrial fusion, teth-
ers contacts between mitochondria and the ER (de Brito and
Scorrano, 2008). Finally, live confocal microscopy has demon-
strated that tethered ER and mitochondria coordinately move
along the cytoskeleton (Rowland and Voeltz, 2012).
Alterations in ER–mitochondria juxtaposition can
compromise lipid metabolism, protein synthesis and folding,
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mitochondrial function and mitochondrial quality control. The
possible changes in ER-mitochondria tethering in senescent
tissues and their involvement in disease pathogenesis has been so
far investigated in the context of neurodegeneration, demonstrat-
ing that improvement of the ER-mitochondria crosstalk sustains
neuronal bioenergetics and exerts a neuroprotective function
(Calì et al., 2013; Nisoli and Valerio, 2014).
The role of eNOS and NO in mediating the ER-mitochondria
relationship is just beginning to be explored. Increased NO
synthesis by eNOS has been described to induce the ER-
mitochondrial chaperone GRP78 and regulate Ca2+ fluxes
between the mitochondria, the Golgi and the ER, thus confer-
ring organ protection in experimental liver transplantation (Ben
Mosbah et al., 2014). It is likely that in the next few years we will
witness to exciting developments in this field.
PEROXISOMAL BIOGENESIS AND CONNECTIONS: A ROLE
FOR NO?
Peroxisomes are remarkably plastic organelles that fulfill impor-
tant functions including fatty acid oxidation, production of tri-
carboxylic acid cycle intermediates for mitochondria and control
of ROS homeostasis (Schrader et al., 2013). Investigation in
recent years has characterized the molecular mechanisms asso-
ciated with peroxisomal biogenesis. The peroxisome membrane
originates from specific ER subdomains or from the growth and
division of pre-existing peroxisomes, on the basis of a well-
defined dynamic sequence: elongation of the organelle membrane
precedes its constriction and final organelle fission (Islinger et al.,
2012). Proteins of the PEX11 family act as membrane elonga-
tion factors, while dynamin-like proteins dictate fission. Notably,
mitochondrial fission proteins such as mitochondrial fission pro-
tein 1 (Fis1), mitochondrial fission factor (Mff) and peroxisomal
and mitochondrial division factor 1 (PMD1) also localize to per-
oxisomes. In contrast to mitochondria, however, peroxisomes do
not undergo fusion (Islinger et al., 2012). PGC-1α—the master
transcriptional co-activator of mitochondrial biogenesis—is also
able to increase peroxisome biogenesis (Bagattin et al., 2010).
Accordingly, our preliminary experiments show that treatment
with the NO donor DETA-NO induces PEX11α and PEX11β
expression in differentiated C2C12 myocytes, thus possibly pro-
moting peroxisome proliferation (Nisoli et al., unpublished). All
in all, peroxisomes and mitochondria share key components
of their division machineries, and are rejuvenated by common
signals and transcriptional pathways (Nisoli and Valerio, 2014).
Peroxisomes and mitochondria interact each other and com-
municate with other subcellular compartments (Camões et al.,
2009). Studies in yeast suggest that protein import into the
peroxisome modulates this interplay (Beach et al., 2012). With
replicative and chronological aging, the decline in the efficiency
of peroxisomal protein import initiates a pro-aging spiral within
this endomembrane system (Titorenko and Terlecky, 2011).
Though our understanding of how peroxisomes are incorpo-
rated into metabolic pathways is just beginning to emerge, the
existence of a peroxisome-mitochondria network suggest pos-
sible implications for human diseases. Indeed, both organelles
are supposed to contribute to age-related pathological condi-
tions including ischemia-reperfusion injury, cancer, T2DM, and
neurodegenerative diseases (Camões et al., 2009), in which NO
does play relevant roles.
ORGANELLE QUALITY CONTROL IS AFFECTED BY AGING
Autophagy is a non-specific cellular degradative pathway con-
served in eukaryotes to assure intracellular organelle quality.
Mitochondrial homeostasis is maintained by several quality-
control mechanisms, including the coordinated events of biogen-
esis, autophagy and the mitochondrial UPR (UPRmt) (Liesa and
Shirihai, 2013; Nisoli and Valerio, 2014).
The selective degradation mechanism for mitochondria is
mitophagy. The mitochondrial quality-control system is mostly
based on fission events, which produce mitochondria with dif-
ferent bioenergetic states. While efficient mitochondria with high
membrane potential are reconnected within the functional mito-
chondrial network through the fusion process, depolarized mito-
chondria are destroyed by mitophagy (Liesa and Shirihai, 2013).
Defects in mitophagy are thought to contribute to age-related
pathology, such as Parkinson’s disease (Youle and Narendra,
2011).
The mitochondrial form of the Lon protease (mLon) is essen-
tial formetabolizing oxidatively damagedmitochondrial proteins.
Its peroxisomal counterpart (pLon) plays a role in eliminating
damaged peroxisomal proteins. Expression and activity of the
Lon proteases declines with age (Titorenko and Terlecky, 2011).
Besides being degraded through non-specific autophagy, peroxi-
somes undergo a specific autophagic process called pexophagy. A
global decrease in lysosomal autophagy and a decline in the pro-
cesses involved in mitochondrial and peroxisomal quality control
have been observed in aged tissues (Beach et al., 2012; Settembre
et al., 2013). Dysfunctional quality control results in the accumu-
lation of mitochondria with altered morphology and/or mem-
brane potential, whose reduced bioenergetic efficiency heavily
contributes to the cumulative damage associated with aging and
metabolic diseases (Nisoli and Valerio, 2014).
Indeed, when autophagic mechanism are unable to meet
the demand for clearance of damaged intracellular organelles,
cell, and organ pathology emerge. In yeast, worms, flies, and
mammals, perturbation of autophagy contributes to accumula-
tion of protein aggregates and dysfunctional mitochondria, and
takes part to the pathogenesis of various age-dependent chronic
diseases resulting in decreased lifespan (Allison et al., 2014).
Interestingly, SIRT1-mediated activation of autophagy is essential
for lifespan extension by CR in worms (Allison et al., 2014).
The role of NO and its downstream signals in autophagy
induction has long been a controversial issue, with studies
describing NO as a suppressor of starvation-induced autophagy
(Sarkar et al., 2011), or indicating NO-based signaling as an
inducer of LPS-mediated autophagy (Yuan et al., 2009). While
NOS inhibition altered mitochondrial dynamics with decreased
fusion and increased fission, this treatment was found to exert
minimal effects on autophagy in the vasculature (Miller et al.,
2013). A recent study demonstrated the role of NO as an
autophagy inducer via its downstream mediator, 8-nitro-cGMP,
in inflammatory conditions (Ito et al., 2013). Interestingly,
eNOS-derived NO stabilizes the autophagy-related protein unc-
51 like kinase (ULK1) and negatively regulated 26S proteasome
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functionality (Xing et al., 2014). The NO-mediated increase of
ULK1 has been recently described as a novel pathway leading
to SIRT1 protein stabilization, though this seems to occur inde-
pendently of autophagy in endothelial cells (Xing et al., 2014).
Nonetheless, given the important implications of autophagy in
various diseases of aging (Allison et al., 2014), the role of NO
signaling in different types of autophagy (ULK1-dependent or
-independent) deserves further investigation.
CONCLUSIONS AND FUTURE PERSPECTIVES
Much progress has been made in clarifying the mechanisms
regulating mitochondrial lifecycle, mitochondrial-organelle com-
munications and organelle quality system. Future challenge is to
deeply investigate the endomembrane system changes in aging
andmetabolic diseases and the contribution of eNOS-derived NO
herein. After more than 30 years since its discovery, we are still
finding unsuspected evidence on the pathophysiological roles of
NO signaling. In particular, eNOS dysregulation takes part to the
pathogenesis of complex-trait metabolic and age-related diseases.
Strategies to maintain the eNOS-NO-PGC-1α pathway within
a physiological range might restore the impaired mitochondrial
bioenergetics of advanced age, possibly mimicking the benefi-
cial effects of CR and moderate exercise (Figure 1). Interestingly,
dietary supplementation with a BCAA-enriched EAA formula
has been demonstrated to restore impaired cardiac and skeletal
muscle mitochondrial biogenesis in an eNOS-dependent man-
ner in aged mice (D’Antona et al., 2010). The BCAA-EAA for-
mula, which is known to exert a variety of beneficial effects in
human subjects, prevented oxidative damage, enhanced physical
endurance and prolonged mean mice survival (D’Antona et al.,
2010; Valerio et al., 2011).
Though still in its infancy, research on the role of the eNOS-
NO system in the control of cell organelle connections and quality
control might reveal exciting avenues for disease treatment in
the coming years. The development of novel therapies aiming to
preserve eNOS-NO signaling will benefit from the identification
of site-specific interaction with the eNOS structure. Efforts to
identify druggable eNOS sites are ongoing (Maron and Michel,
2012). Groundbreaking research is also taking into consideration
uncoupled eNOS as a druggable target (Li and Förstermann,
2014). Some drugs in clinical use (including statins and various
inhibitors of the renin-angiotensin-aldosterone system) have
been shown to prevent eNOS uncoupling under experimental
conditions. Since eNOS uncoupling is reversible, it should be of
interest to identify conventional drugs or food able to recouple
eNOS, switching it back to a well-functioning, NO producing
enzyme. The eNOS transcription enhancers AVE9488 and
AVE3085 are promising molecules also acting as eNOS recouplers
(Li and Förstermann, 2014). Resveratrol can reverse eNOS
uncoupling by increasing BH4 producing enzyme, but has poor
bioavailability (Li and Förstermann, 2014). Small molecules act-
ing as specific SIRT1-activating compounds (the so-called STACs)
possibly intervening in the SIRT1-eNOS activity loop (Guarente,
2013) also deserve to be investigated in this context. Although
our knowledge about the therapeutical usability of the proposed
eNOS-targeting molecules in the long-term is limited, further
research might provide the market with novel pharmaceuticals
or nutraceuticals with fundamental health-promoting
effects.
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